Literature DB >> 17588133

Effects and mechanisms of Paeoniflorin, a bioactive glucoside from paeony root, on adjuvant arthritis in rats.

Y-Q Zheng1, W Wei, L Zhu, J-X Liu.   

Abstract

OBJECTIVE AND
DESIGN: Paeoniae alba Radix has been recognized as a valuable herb in the treatment of rheumatoid arthritis (RA) in traditional Chinese medicine. The purpose of this study was to investigate the effects of Paeoniflorin (PF), a bioactive glucoside from paeony root, on the rats with adjuvants arthritis (AA) and underlying mechanisms. MATERIALS: AA was induced by injecting Complete Freund's adjuvant (10 mg/ml) into hind paw in male Sprague-Dawley rats. TREATMENT: PF (5, 10, 20 mg/kg/d) was orally administered to the rats 14 to 20 days after injection of complete Freund's adjuvant.
METHODS: Arthritis was evaluated by hind paw swelling, polyarthritis index, immune organ weights, and histological examination. Interleukin-1 (IL-1) activity was assessed by thymocyte proliferation as quantified by the 3-(4, 5-2dimethylthiazal- 2yl) 2,5-diphenyltetrazoliumbromide (MTT) assay. The content of prostaglandin E2 (PGE2) was measured by radioimmunoassay. The levels of IL-6, granulocyte macrophage colony stimulating factor (GM-CSF) and vascular epidermal growth factor (VEGF) in synovium homogenates were measured by enzyme-linked immuno-absorbent assay (ELISA) respectively. Expression of inhibitory subunits of G protein (G i) and cyclo-oxygenase-2 (COX-2) were detected by Western blotting technique.
RESULTS: There were significant secondary inflammatory reactions in AA rats, which were accompanied by a decrease in immune organ weights. The administration of PF (10, 20 mg/kg/day, i. g., days 14-20) inhibited the inflammatory response and restored the weight of immune organs of AA rats. Synoviocyte proliferation of AA rats increased significantly, and the levels of IL-1, PGE2, IL-6, VEGF and GM-CSF in synovial homogenates of AA rats were also elevated compared with the normal group. The administration of PF (10, 20 mg/kg/day, i.g., days 14-20) reduced the above changes significantly. Finally, the expression of Gi1, Gi2, Gi3 and COX-2 in synovial homogenates of AA rats were also elevated. The administration of PF reduced Gi expression at doses of 10 and 20 mg/kg and decreased COX-2 expression at a dose of 20 mg/kg.
CONCLUSION: PF suppresses rat AA at least partly by inhibiting abnormal proliferation of synoviocytes and the production of IL-1, PGE2, IL-6, VEGF and GM-CSF by synoviocytes and reducing Gi and COX-2 expression in synovium.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17588133     DOI: 10.1007/s00011-006-6002-5

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  36 in total

1.  Paeoniflorin Suppressed High Glucose-Induced Retinal Microglia MMP-9 Expression and Inflammatory Response via Inhibition of TLR4/NF-κB Pathway Through Upregulation of SOCS3 in Diabetic Retinopathy.

Authors:  Su-Hua Zhu; Bing-Qian Liu; Mao-Juan Hao; Yi-Xin Fan; Cheng Qian; Peng Teng; Xiao-Wei Zhou; Liang Hu; Wen-Tao Liu; Zhi-Lan Yuan; Qing-Ping Li
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

2.  Immunoregulatory Effects of Paeoniflorin Exerts Anti-asthmatic Effects via Modulation of the Th1/Th2 Equilibrium.

Authors:  Tianzhu Zhang; Zhaocong Yang; Shihai Yang; Juan Du; Shumin Wang
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

Review 3.  G protein coupled receptors signaling pathways implicate in inflammatory and immune response of rheumatoid arthritis.

Authors:  Jinling Shu; Feng Zhang; Lingling Zhang; Wei Wei
Journal:  Inflamm Res       Date:  2016-11-23       Impact factor: 4.575

4.  Paeoniflorin protects against lipopolysaccharide-induced acute lung injury in mice by alleviating inflammatory cell infiltration and microvascular permeability.

Authors:  Haiqiang Zhou; Difei Bian; Xiaolan Jiao; Zhifeng Wei; Haofang Zhang; Yufeng Xia; Yisheng He; Yue Dai
Journal:  Inflamm Res       Date:  2011-07-12       Impact factor: 4.575

5.  Herbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome.

Authors:  Feng-yun Wang; Min Su; Yong-qiu Zheng; Xiao-ge Wang; Nan Kang; Ting Chen; En-lin Zhu; Zhao-xiang Bian; Xu-dong Tang
Journal:  Acta Pharmacol Sin       Date:  2015-05-11       Impact factor: 6.150

6.  Paeoniflorin ameliorates rheumatoid arthritis in rat models through oxidative stress, inflammation and cyclooxygenase 2.

Authors:  Zhilin Jia; Jiao He
Journal:  Exp Ther Med       Date:  2015-12-02       Impact factor: 2.447

7.  Paeoniflorin inhibits inflammatory responses in mice with allergic contact dermatitis by regulating the balance between inflammatory and anti-inflammatory cytokines.

Authors:  Chun Wang; Jun Yuan; Hua-Xun Wu; Yan Chang; Qing-Tong Wang; Yu-Jing Wu; Li-Hua Liu; Wei Wei
Journal:  Inflamm Res       Date:  2013-10-05       Impact factor: 4.575

8.  Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.

Authors:  Yu Ji; Yan-Nong Dou; Qian-Wen Zhao; Ji-Zhou Zhang; Yan Yang; Ting Wang; Yu-Feng Xia; Yue Dai; Zhi-Feng Wei
Journal:  Acta Pharmacol Sin       Date:  2016-05-02       Impact factor: 6.150

9.  Clinical study of total glucosides of paeony for the treatment of diabetic kidney disease in patients with diabetes mellitus.

Authors:  Qijin Zhu; Xiangming Qi; Yonggui Wu; Kun Wang
Journal:  Int Urol Nephrol       Date:  2016-06-24       Impact factor: 2.370

10.  Paeoniflorin attenuates hepatic ischemia/reperfusion injury via anti-oxidative, anti-inflammatory and anti-apoptotic pathways.

Authors:  Y E Tao; Zhihong Wen; Yingqian Song; Hui Wang
Journal:  Exp Ther Med       Date:  2015-11-27       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.